BACE1 is an indispensable enzyme for generating b-amyloid peptides, which are excessively accumulated in brains of Alzheimer's patients. However, BACE1 is also required for proper myelination of peripheral nerves, as BACE1-null mice display hypomyelination. To determine the precise effects of BACE1 on myelination, here we have uncovered a role of BACE1 in the control of Schwann cell proliferation during development. We demonstrate that BACE1 regulates the cleavage of Jagged-1 and Delta-1, two membrane-bound ligands of Notch. BACE1 deficiency induces elevated Jag-Notch signaling activity, which in turn facilitates proliferation of Schwann cells. This increase in proliferation leads to shortened internodes and decreased Schmidt-Lanterman incisures. Functionally, evoked compound action potentials in BACE1-null nerves were significantly smaller and slower, with a clear decrease in excitability. BACE1-null nerves failed to effectively use lactate as an alternative energy source under conditions of increased physiological activity. Correlatively, BACE1-null mice showed reduced performance on rotarod tests. Collectively, our data suggest that BACE1 deficiency enhances proliferation of Schwann cell due to the elevated Jag1/ Delta1-Notch signaling, but fails to myelinate axons efficiently due to impaired the neuregulin1-ErbB signaling, which has been documented. 
Hou, & Yan, 2016; Mei and Nave, 2014) and BACE1 can cleave both types I and III b1 Nrg1 (Fleck, Van, Colombo, Galante, Schwenk, Rabe, . . . Haass, 2013; Hu et al., 2008; La, Cerri, Horiuchi, Bachi, Feltri, Wrabetz, . . . Taveggia 2011) . After nerve crush, type I Nrg1 is also required for optimal remyelination of regenerated axons, as mice deficient in axonal Nrg1 are initially hypomyelinated (Fricker, Lago, Balarajah, Tsantoulas, Tanna, Zhu, . . . Bennett 2011; Stassart, Fledrich, Velanac, Brinkmann, Schwab, Meijer, . . . Nave, 2013) but eventually attain levels of remyelination comparable to wild-type (WT) nerves (Fricker, Antunes-Martins, Galino, Paramsothy, La, Perkins, . . . Bennett, 2013) . This indicates that axonal Nrg1 is required for initial phases of remyelination. Further studies suggest that type I Nrg1 in Schwann cells, rather than axonal type III Nrg1, contributes to remyelination, as loss of Nrg1 expression in Schwann cells severely impairs remyelination after nerve crush (Stassart et al., 2013) . Consistent with this observation, we have recently shown that BACE1 in Schwann cells is required for remyelination, as demonstrated in a nerve transplantation experiment using BACE1-null and WT Schwann cells (Hu, Hu, Dai, Trapp, & Yan, 2015) . We also showed that nerve injury induces expression of BACE1 and type I Nrg1 in Schwann cells and that BACE1-cleaved Nrg1 mediates remyelination following sciatic nerve crush. Type III Nrg1 is sparsely detected in Schwann cells, indicating that optimal remyelination requires type I Nrg1 in Schwann cells and type III Nrg1 in axons (Stassart et al., 2013) .
During remyelination of peripheral nerves in BACE1-null mice, we observed a significant increase in glial fibrillary acidic protein (GFAP) levels in Schwann cells (Hu, He, Luo, Tsubota, & Yan, 2013) , which supports the possibility that Schwann cell proliferation is increased in BACE1-null peripheral nerves. Why increased proliferation of Schwann cells leads to hypomyelination, rather than hypermyelination, in BACE1-null mice remains to be determined. Therefore, we investigated Schwann cell maturation, myelin internode ultrastructure, and the molecular mechanism underlying increased proliferation of Schwann cells upon BACE1 ablation. We found that BACE1 deficiency abolished cleavage of Jagged-1/Delta-1 and increased Notch signaling activity, which promotes proliferation of Schwann cells. However, the increased number of Schwann cells failed to enhance myelination due to reduced Nrg1 signaling in BACE1-null axons. BACE1-null mice exhibited a decrease in myelin internodal length and Schmidt-Lanterman incisures.
Functional assays revealed significantly impaired peripheral nerve conduction and motor performance on the rotarod test. These studies link alterations in Jag-Notch signaling with the control of Schwann cell proliferation. Collectively, our data show that BACE1 in both axons and Schwann cells is indispensable for normal peripheral nerve function.
| MATERIALS A ND METHODS

| Animals
BACE1-null mice were generated as described in the original publication (Cai, Wang, McCarthy, Wen, Borchelt, Price, & Wong, 2001 ) and maintained in a C57BL/6 background. All animal use and procedures were first described and submitted for approval by the Institutional Animal Care and Use Committee at the Lerner Research Institute and in compliance with the guidelines established by the Public Health Service Guide for the Care and Use of Laboratory Animals.
| Electrophysiology of nerve conduction
Adult WT and BACE1-null male mice at 1 month of age were euthanized after CO 2 asphyxiation. A lateral incision was made to expose the hind limb muscles. The sciatic nerve was identified, traced along its length, and cut proximally close to the spinal column and distally before the branching of the nerve. The sciatic nerve was gently freed from the surrounding tissue and placed in an interface perfusion chamber (Medical Systems, Greenvale, NY). Nerves were maintained at 378C and perfused with artificial cerebrospinal fluid (aCSF) that contained (in mM):
124 NaCl, 3.0 KCl, 2.0 CaCl 2 , 2.0 MgCl 2 , 1.25 NaH 2 PO 4 , 23 NaHCO 3 , and 10 glucose. The aCSF was bubbled with a 5% CO 2 -containing gas mixture (95% O 2 , 5% CO 2 ) to maintain pH at 7.45. The nerve was continuously exposed to a moisturized gas mixture containing 95% O 2 and 5% CO 2 . Suction electrodes filled with aCSF were attached to the nerve for stimulation and recording of compound action potentials (CAPs) after the nerves were equilibrated for 60 min. CAPs were evoked every 30 s and stimulus strength was adjusted to evoke the maximum CAPs and then increased another 25% to ensure that stimulus strength was always supramaximal (A365R Stimulus Isolator, WPI, Sarasota, FL). All experiments were performed using an Axoclamp 900A amplifier (Molecular Devices Inc, Sunnyvale, CA) interfaced to a personal computer with a Digidata 1400A analog/digital interface and the pCLAMP 10.2 software package (Molecular Devices, Sunnyvale, CA). Signals were amplified 50 times, low-pass filtered at 100 kHz (SR560, Stanford Research Systems, Sunnyvale, CA), and digitized at 50 kHz before being stored for offline analysis. Areas under CAPs were measured to quantify and compare axon function. The CAP area, time to peak (latency), peak amplitude, and peak duration were measured using Clampfit 10.2 software (Molecular Devices, Sunnyvale, CA).
CAP areas were normalized to the baseline condition. To study axon function response to a physiological stressor, two sets of high frequency stimulations (100 Hz for 4 min and 100 Hz for 10 min) were applied sequentially after an initial baseline period, with 15 min of recovery in between. After the last high frequency simulation, nerves were allowed to recover for at least 2 h. To determine axon excitability, nerves were stimulated using a range of different stimulus intensities from minimum to maximum with stepwise increments to determine threshold to evoke a CAP and maximal stimulation to generate stimulus intensity curves. All data were normalized to the control values.
| Schwann cell primary cultures
Five-day-old pups (P5) were killed by decapitation and cleaned by brief submersion in 70% ethanol. Both sides of sciatic nerves were dissected out and digested with 2 mL of PBS containing 0.125% trypsin and 0.05% collagenase A for 30 min at 378C. After washing with DMEM medium containing 10% horse serum and centrifuging at 190g for 5 min, the pallet cells were suspended in Schwann cell basic growth medium (DMEM containing 10% horse serum, 2 ng mL 21 neuregulin1-b1, 100 U mL 21 penicillin and streptomycin, 2 mM L-glutamine, and 0.5 mM forskolin) and plated on ploy-L-lysine coated 60-mm culture dishes, with medium being changed every 3 days. Six days after culturing, cells were treated with 4 mg mL 21 of anti-mouse Although WT nerves are thicker than BACE1-null nerves, the average number of myelinating Schwann cells, in which EGR2 is mainly expressed (Jessen and Mirsky, 2002) , was greater in BACE1-null nerves than in WT controls in both age groups ( Figure 1D ).
Furthermore, we stained nerve sections from the same age groups with an antibody to Sox10, which is a critical regulator of Schwann cell myelination (Britsch, Goerich, Riethmacher, Peirano, Rossner, Nave, . . . Figure 1E ; n 5 7 sections, three animals in each group, p < 0.01, Student's t test). In 3-month-old nerves, the number of Sox10-labeled Schwann cells was also greater in BACE1-null 
| BACE1 deficiency promotes proliferation of Schwann cells
To determine whether the increased number of Schwann cells in BACE1-null nerves is due to increased Schwann cell proliferation, we performed BrdU pulse labeling experiments using P8 mice. Twentyfour hours after intraperitoneal injection of BrdU, we examined BrdUpositive nuclei in fixed sciatic nerve sections. We detected more BrdUpositive nuclei in BACE1-null nerves compared to WT littermate controls ( Figure 3A ,B; 30.14 6 2.36 BrdU 
| BACE1 deficiency shortens internodes and paranodes
We next investigated whether increased myelinating Schwann cells would alter internodal length and/or paranodal structures in BACE1- FIG URE 4 Shortened internodal and paradonal lengths in BACE1-null nerves. (A) Fixed sciatic nerves from 1-month-old mice were labeled with an antibody to Caspr, which is localized in the paranodal section and is circled in red. BACE1-null nerves showed increased numbers of nodes and reduced overall paradonal lengths. Scale bar is 40 lm. (B) Teased nerves were prepared from 4-month-old mice to compare internodal length flanked by two nodes (green arrow) as well as Schmidt-Lanterman incisures (red arrow). As shown, internodal lengths were shortened, while Schmidt-Lanterman incisures within an internode were decreased in BACE1-null nerves compared to control nerves. The average internodal length was 618.0 6 23.0 mm in WT axons compared to 461.0 6 20.0 mm in BACE1-null axons, while the average number of Schmidt-Lanterman incisures within an internode was 20.9 6 1.2 in WT axons compared to 13.4 6 0.7 in BACE1-null axons (**p < 0.01, n 5 40). Scale bar is 50 lm.
(C) Axons of BACE-null sciatic nerves were examined using 3D EM (a-b, composites from multiple slices; c, single slice) and showed normal nodal ultrastructure, including regularly spaced paranodal loops (*) that closely apposed the axolemma (arrowheads). Some fibers (a) had comparatively short paranodal regions (small arrows) compared with most others (b). Abbreviations: m, compact myelin; c endoneurial collagen fibrils. Scale bars are 1 mm in a and b, 0.25 mm in c. (D) The paranodal length was compared by utilizing the captured 3D-EM images and plotting correlations with axonal width. Larger axons tended to have shorter paranodal length in BACE1-null nerves compared to those in smaller axons. (E) Sciatic nerves from 3-month-old mice were fixed and labeled with antibody to NCAM, which also marks Schmidt-Lanterman incisures. There were less Schmidt-Lanterman incisures in all examined BACE1-null sciatic nerves compared to WT controls null sciatic nerves. Fixed sciatic nerve sections were labeled with an antibody specific to caspr, which is an axonal membrane protein normally localized in paranodal axolemma (Dupree, Girault, Popko, 1999) .
The number of paranodes was dramatically increased in BACE1-null sciatic nerves compared to WT controls ( Figure 4A : 120.6 6 21.9 per 100,000 mm 2 in WT vs. 286.9 6 46.0 in BACE1-null sciatic nerves, n 5 5 animals, p < 0.01, Student's t test), suggesting a shortened internodal length in BACE1-null mice. When internodal length was examined in teased sciatic nerve fibers ( Figure 4B ), the internodes of BACE1-null sciatic nerves were visibly shorter compared to WT controls. Further quantification revealed that the internodal length of WT sciatic nerves was 618.0 6 23.0 lm, while that of BACE1-null sciatic nerves was 461.0 6 20.0 lm on average (p < 0.01, n 5 40).
Morphologically, nodes of Ranvier are arranged as short gaps between two adjacent myelinated segments or internodes (Girault and Peles, 2002; Poliak and Peles, 2003) . The above caspr staining of nodes indicated that paranodal staining was reduced in intensity and asymmetrically distributed across BACE-null nodes compared to WT nodes (red circles, Figure 4A ). To further examine the nodal ultrastructure, we examined nodes using serial blockface scanning electron microscopy (SEM), which provides serial-sectioned images of entire paranodal/nodal regions with nanometer resolution.
Surprisingly, there appeared to be no major differences in paranodal ultrastructure between WT and BACE1-null axons (data not shown).
Myelin lamellae terminate as cytoplasmic loops on the paranodal axolemma (see example in Figure 4C ). Although outpocketing and crennelation of juxtaparanodal compact myelin were seen in BACEnull axons, major disruptions, such as paranodal loops displaced from the axolemma or terminating internodally, tomacular overgrowth, or myelin breakdown, were not detected. Despite no obvious ultrastructural differences, measurements of paranodal distance (first to last paranodal loop) revealed shorter paranodal length in large sizes of BACE-null axons (diameter >2 mm) compared to controls, but not obvious in smaller axons ( Figure 4D ). Reduced caspr staining at BACE-null nodes is likely to reflect fewer paranodal loops due to fewer compact myelin lamellae. Despite no overt change in nodal ultrastructure, we cannot eliminate the possibility that the molecular architecture of paranodal loops is disrupted without major changes in axoglial organization.
In Figure 4B , we also noted less Schmidt-Lanterman incisures within an internode in BACE1-null sciatic nerves ( Figure 4B ; 20.9 6 1.2 in WT vs. 13.4 6 0.7 in BACE1-null nerves; p < 0.01, n 5 40). Reduced numbers of Schmidt-Lanterman incisures were also evident when fixed BACE1-null sciatic nerves were stained with an antibody specific to N-CAM, a neuronal surface adhesion molecule ( Figure 4E ). Collectively, BACE1 deficiency results in shortened internodal lengths, decreased Schmidt-Lanterman incisures, and altered nodes of Ranvier in large axons.
| BACE1 deficiency impairs nerve conduction
To determine the impact of altered Schwann cell proliferation on axonal excitability and conduction properties, we measured compound action potentials (CAPs) evoked in isolated sciatic nerves from BACE1-null and WT mice ( Figure 5A ). Sciatic nerves were placed in between two suction electrodes delivering stimulation to the proximal side and recording Consistent with the altered axonal conduction properties, deletion of BACE1 caused a drastic decrease in axon excitability, as demonstrated by a prominent rightward shift in stimulus intensity plots (Figure 5F ). The threshold to evoke a CAP increased from 50 to 100 mA in BACE1-null mice ( Figure 5F , arrows). This shift suggests a direct role for BACE1 and resultant hypomyelination in regulating axon excitability and conduction.
| BACE1 deficiency impairs rotarod performance and metabolic responses
Considering the altered nerve structure and myelination as well as the alterations in nerve conduction, we asked whether BACE1-null mice would behave differently on the rotarod performance test, which evaluates balance, endurance, and motor coordination. BACE1-null mice showed significantly impaired behaviors on the rotorod test, as the latency of falling from the rotarod was significantly reduced in two age groups of BACE1-null mice ( Figure 6A : 134.2 6 13.2s in 3-month-old WT vs. 103.5 6 10.1s in BACE1-null mice; 164.2 6 14.1s in 10-monthold WT vs. 125.6 6 12.7s in BACE1-null mice, n 5 20 mice in each group, p < 0.01). Impaired rotarod performance in BACE1-null mice is consistent with the corresponding impairment in nerve conduction properties.
On the other hand, the impaired performance of BACE1-null mice on the rotarod test might also be attributable to altered energy utilization, especially during high physical activity (Baltan, 2015; Brown, Tekkok, & Ransom, 2003; Tekkok, Brown, Westenbroek, Pellerin, & Ransom, 2005) . High frequency stimulation (HFS) is a physiological challenge that can assess the ability of peripheral nerves to switch from glucose to lactate as an energy source (Evans, Brown, & Ransom, 2013) . Exposing sciatic nerves obtained from WT nerves to HFS (100 Hz) for 4 min (short) or 10 min (long) showed that CAPs instantly recovered to baseline levels after 4 min HFS and recovered to 90% 6 0.12 6 0.11 in 6 BACE1-null nerves, p 5 0.0008, two-tailed Student's t test). Axons alternate between glucose and lactate as an energy source, but prefer lactate during intense activity or when glucose levels are low (Baltan, 2015; Brown et al., 2003; Tekkok et al., 2005; ) . Irreversible depression in axon function following increased activity suggests that;
(1) BACE1 deletion may impair glycogen storage in Schwann cells so that lactate cannot be produced, (2) glycogen is present and converted to lactate but cannot be delivered to axons due to a reduction and/or depletion of MCT1 (Morrison, Tsingalia, Vidensky, Lee, Jin, Farah, . . . Rothstein, 2015) , and (3) lactate is produced and delivered properly but axonal mitochondria cannot use lactate due to dysfunction. BACE1 seems to play an important role in axonal metabolic responses during a physiological challenge such as HFS; therefore, the above mechanisms are currently under further investigation.
| BACE1 deficiency alters Jag-notch signaling function
To understand the molecular mechanism underlying increased Schwann cell proliferation, we examined changes in relevant proteins.
Sciatic nerves in 1-month-old mice were used for western blot analysis.
We found that BACE1-null samples showed significantly elevated levels of full length Jag1 and Delta1, but not full length Jag2 ( Figure 7A ). This is consistent with previous studies demonstrating that Jag1 is more effectively cleaved by BACE1 than Jag2 (He, Hu, Xia, & Yan, 2014; Hu et al., 2013) . Jag1 and Delta1 are membrane-anchored ligands of Notch molecules and their binding to Notch induces activation of Notch by inducing release of Notch Intracellular Domain (NICD). Levels of NICD were significantly increased in BACE1-null nerves compared to WT controls ( Figure 7A, C) . In addition, levels of Jag1, Delta1, and NICD were significantly increased in Schwann cells isolated from P5 BACE1-null mice ( Figure 7B ). Further quantification confirmed a significant increase in NICD levels in BACE1-null Schwann cells ( Figure 7D ), suggesting that reduced processing of these Notch ligands by BACE1 increases Notch signaling activity on the cell surface.
This is mechanistically important, as our data are in line with a prior report that enhanced Notch activity promotes Schwann cell proliferation (Woodhoo, Alonso, Droggiti, Turmaine, D'Antonio, Parkinson, . . .
Jessen, 2009).
| Mapping the cleavage site of delta1 by BACE1
We have previously confirmed cleavage of Jag1 by BACE1 (He et al., 2014) . To confirm the cleavage of Delta1 by BACE1, we synthesized one long peptide with 40 amino acids (GYVCECAR GYGGPNCQFLLPELPPGPAVVDL-TEKLEGQGG), which spans the immediate ectodomain region, for mapping the cleavage site as discussed previously (Hu et al., 2008; Luo, Prior, He, Hu, Tang, Shen, . . . Yan, 2011) . This peptide potentially contains the putative cleavage sites based on our initial sequence analysis. Cleavage of this peptide, which showed high purity and had the expected molecular weight ( Figure 8A ), by recombinant BACE1 in our enzymatic assay showed that BACE1 cleaved Delta1 mainly between DL-TE ( Figure 8B ). This cleavage site is nine amino acids upstream of the Delta1 transmembrane domain and is comparable to that in Jag1 and Nrg1 (He et al., 2014; Hu et al., 2008) . We also observed another cleavage product between VC-EC at the N-terminal side of this peptide, as the cleaved product matched molecular mass ( Figure   8B ). In the case of APP and Jag1, two BACE1 cleavage sites were also present (He et al., 2014; Liu, Doms, & Lee, 2002; Qahwash, He, Tomasselli, Kletzien, & Yan, 2004) . While future mutagenesis will be performed to explore which site will site is predominant, this mapping study shows that Delta1 has BACE1 cleavage sites similar to Jag1.
| DISCUSSION
BACE1 is a membrane-anchored aspartyl protease; its physiological substrates are membrane-bound proteins (Dislich, Wohlrab, Bachhuber, Mueller, Kuhn, Hogl, . . . Lichtenthaler, 2015; Hemming, Elias, Gygi, & Selkoe, 2009; Kuhn et al., 2012; Yan et al., 2001) . While BACE1 inhibition will benefit Alzheimer's patients by reducing excessive accumulation of Ab peptides, BACE1 inhibition also likely affects cellular processes associated with inhibited cleavages of other BACE1 substrates. Previous studies have focused on the role of BACE1-cleaved Nrg1 in axons (Hu et al., 2016; Fleck, Garratt, Haass, & Willem, 2012) .
We show here that BACE1 regulates peripheral nerve myelination by directly altering the size and functions of myelinating Schwann cells.
This study provides the first evidence that BACE1 also controls myelination by directly regulating Jag1/Delta1-Notch activity in Schwann cells.
In developing peripheral nerves, immature Schwann cells are known to differentiate into mature myelinating Schwann cells and non-myelinating Schwann cells (Jessen and Mirsky, 2005; Monk, Feltri, & Taveggia, 2015) . Non-myelinating Schwann cells usually corresponding to the sequence upstream of the trasmembrane domain was purified and confirmed by mass spectrometry. This peptide was incubated with recombinant BACE1 for enzymatic assays. (B,C) Mapping analysis of BACE1-cleaved peptides in the enzymatic reaction by MOLDI-TOF mass spectrometry revealed one major C-terminal peak with a molecular weight of 918.5 and corresponding to the peptide TEKLEGQGG (B). In the N-terminal side, BACE1 can also cleave between the VC-EC site and produce a smaller product with a molecular weight of 2852.3, as well as the longer one of 3232.4 as illustrated next to the peak (C) bundle small axons (<1 mm diameter) into Remak bundles, while myelinating Schwann cells associate with and ensheath larger axons in a 1:1 ratio (Roberts and Lloyd, 2012 (Michailov et al., 2004; Taveggia et al., 2005) . BACE1 in axons cleaves this Nrg1 isoform and this cleavage is indispensable, as BACE1-null nerves display hypomyelination (Fleck et al., 2013; Hu et al., 2006; La et al., 2011; Luo et al., 2011; Willem et al., 2006) . Neuronal overexpression of an equivalent form of BACE1-cleaved Nrg1 type III variant induces hypermyelination in vivo and restores myelination of NRG1 type IIIdeficient neurons (Velanac, Unterbarnscheidt, Hinrichs, Gummert, Fischer, Rossner, . . . Schwab, 2012) .
On the other hand, intrinsic signals from Schwann cells are equally important for proper myelination and we have provided experimental evidence of this in this study. First, we showed that BACE1 is expressed by cultured primary Schwann cells ( Figure 7B ).
A previous study suggested that BACE1 was not readily detected in Schwann cells by in situ hybridization (Willem et al., 2006) , and this is related to high expression of BACE1 in neurons. By using a sensitive western blot assay, we detected BACE1 in cultured primary Schwann cells in the absence of axons. We previously also showed that injury induces expression of BACE1 in Schwann cells, likely due to inflammatory responses (Hu et al., 2015) . Second, we observed increased Schwann cell proliferation in BACE1-null nerves during development (Figures 1 and 2 ) and after injury (data not shown). During normal nerve development, the number of Schwann cells is often matched to the number and length of axons (Jessen and Mirsky, 1998) . The increased number of Schwann cells is unlikely due to reduced signaling from axonal Nrg1, as Nrg1 promotes the maturation and survival of Schwann cells (Garratt, Britsch, & Birchmeier, 2000; Nave and Salzer, 2006; Zorick and Lemke, 1996) . Instead, it is likely due to autocrine signaling from the enhanced Jag1/Delta1-Notch pathway, as all of these molecules are intrinsically expressed by cultured Schwann cells ( Figure   7 ). This speculation is supported by a prior publication showing that Notch signals the generation of Schwann cells from Schwann cell precursors and regulates the size of the Schwann cell pool by controlling proliferation (Woodhoo et al., 2009) . We showed that full length Jag1 and Delta1 are elevated in BACE1-null nerves and Schwann cells. Our previous mapping study confirmed that Jag1 is a natural substrate of BACE1 (He et al., 2014) and that abolished cleavage of Jag1 in BACE1-null Schwann cells increases the level of full length Jag1. This study provides further evidence that Delta1 is also an effective substrate of BACE1 and two potential cleavage sites were identified (Figure 8 ). It appears that Jag2 is mostly expressed by axons, as its expression in Schwann cells was extremely low. The elevation of both Jag1 and Delta1 would induce sequential proteolytic cleavages of Notch for enhanced release of NICD (Kopan and Ilagan, 2009) , and enhanced NICD promotes Schwann cell proliferation (Woodhoo et al., 2009) . Third, the size of Schwann cells appeared to be smaller in BACE1-null nerves. During development, Schwann cell size is determined by the regulation of cell growth, and cell division proliferation is inversely correlated (Roberts and Lloyd, 2012) Nrg1 hemi-mice also showed defects in Remak bundles (Fricker, Zhu, Tsantoulas, Abrahamsen, Nassar, Thakur, . . . Bennett, 2009; Taveggia et al., 2005) . Hence, BACE1 is required as a check point protein for regulating Schwann cell proliferation.
BACE1 deficiency appears to disrupt normal functions of
Schwann cells as demonstrated in our electrophysiological recordings and behavioral testing. The ability of peripheral nerves to switch from glucose to lactate as an energy source is a physiological response to increased stress, which relies on the Schwann cellaxon lactate shuttle or normal mitochondrial functions in Schwann cells (Evans et al., 2013) , and this ability is defective in BACE1-null nerves ( Figure 6B ). Glucose and lactate are equally efficient in supporting peripheral and central nerve function (Baltan, 2015; Brown et al., 2004 Brown et al., , 2012 Evans et al., 2013; Tekkok et al., 2005; ) . Excess glucose is stored as glycogen in Schwann cell cytoplasm (Brown et al., 2012) , and glycogen is broken down into lactate to support axon function when ambient glucose levels are low/depleted or when there is an increase in neuronal/axonal activity (Brown et al., 2003 Evans et al., 2013 Hypomyelination found in BACE1-null mice was initially attributed to the reduced cleavage of type III Nrg1 (Hu et al., 2006; Willem et al., 2006) , and growing evidence supports the requirement of BACE1-dependent Nrg1 signaling functions in the control of myelin sheath thickness [see reviews by (Birchmeier and Nave, 2008; Fleck et al., 2012; Hu et al., 2016; Mei and Nave, 2014) ]. Results from this study further suggest BACE1 as a check point protein by regulating Schwann cell myelination and cellular functions through the Nrg1-Erb2/3 and Jag1/Delta1-Notch pathways via either paracrine or autocrine fashions. BACE1 deficiency enhances proliferation of Schwann cell due to the elevated Jag1/Delta1 levels, but fails to myelinate axons efficiently due to impaired the paracrine Nrg1 signaling. Axon-Schwann cell metabolic coupling is also disrupted, although the detailed molecular mechanisms remain to be established.
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